Counseling sexually active teenagers treated with potential human teratogens

Kathleen Shilalukey, Miriam Kaufman, Susan Bradley, William H. Francombe, Koffi Amankwah, Eudice Goldberg, Neil Shear, Nancy F. Olivieri, Gideon Koren

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Adolescents with hemoglobinopathies need daily chelation therapy with drugs which are known or suspected to be teratogenic. The prevention Of fetal exposure to such drugs is therefore a major task for health professionals caring for these patients. We describe a pilot program aiming to prevent pregnancy among sexually active adolescents treated with iron chelators in Toronto. Most of them had normal response to GnRH, suggesting endocrinologic fertility, and unlike the literature concerning their healthy peers, all sexually active patients in this study reported use of at least one form of contraception.

Original languageEnglish
Pages (from-to)143-146
Number of pages4
JournalJournal of Adolescent Health
Volume21
Issue number3
DOIs
StatePublished - Sep 1997
Externally publishedYes

Keywords

  • Adolescents
  • Counseling
  • Iron chelators
  • Teratogens

Fingerprint

Dive into the research topics of 'Counseling sexually active teenagers treated with potential human teratogens'. Together they form a unique fingerprint.

Cite this